Navigation Links
JDRF announces 2008 Spring Research Review Award

The Juvenile Diabetes Research Foundation recently awarded its top honors to three noted scientists. The awards were presented at the 2008 Spring Research Review Awards Dinner.

The David Rumbough Award for Scientific Excellence was established in 1974 by the actress Dina Merrill, in honor of her late son, David. It is the highest honor JDRF awards, and is presented annually to researchers for outstanding achievement and commitment to diabetes research and for their service to JDRF. Michael Brownlee, MD, and Michael German, MD, received the 2008 Rumbough Award.

The Gerold & Kayla Grodsky Basic Research Scientist Award is presented annually to a basic research scientist who has made outstanding contributions to diabetes research. JDRF established the award in 1993 to honor the contributions of Dr. Grodsky's diabetes research at University of California at San Francisco (UCSF) over four decades. This years recipient is Maike Sander, MD.

Of the presentation, Dina Merrill said she was honored to join with you tonight in the presentation of the David Rumbough Award for Scientific Excellence, which was established in honor of my late, beloved son, David. He would have been very pleased to know that research towards a cure is progressing rapidly and improving the lives of so many. Keep up the good work.

Michael Brownlee, MD, the Anita and Jack Saltz Professor of Diabetes Research at Albert Einstein College of Medicine is one of the most respected and influential scientists in his field. He is noted for his innovative approach to understanding the biochemical basis of diabetic complications. Internationally recognized for his research, Dr. Brownlee discovered a novel molecular pathway linking hyperglycemia to diabetic retinopathy, a complication of the disease.

Dr. Brownlee is also the Director of the JDRF International Center for Diabetic Complications Research. All of the projects in this Center share an overriding aim: to develop innovative, highly effective therapies for preventing the development and progression of retinopathy, nephropathy, neuropathy, and atherosclerosis in type 1 patients. In 2006, JDRF awarded Dr. Brownlee with the Scholar Award.

His other scientific awards include the American Diabetes Associations Banting Medal and Outstanding Scientific Achievement Award, the European Association for the Study of Diabetes Claude Bernard Medal, Columbia Universitys Naomi Berrie Award, and Duke University Medical Schools Distinguished Alumnus Award.

Michael German, MD, is a Professor in the Department of Medicine at UCSF, Associate Director and Clinical Director of the UCSF Diabetes Center, Director of the Hillblom Islet Genesis Network and the UCSF NIH Diabetes and Endocrinology Research Center (DERC), and a Principle Investigator in the Hormone Research Institute. Understanding the structure and development of pancreatic beta cells is the main focus of Dr. Germans research. He is the recipient of three other awards given by JDRF: the Scholar Award (2007), Living and Giving Award (2004), and Career Development Award (1991-1994).

Maike Sander, MD, Associate Professor in the Department of Developmental & Cell Biology at the School of Biological Sciences at the University of California at Irvine and the recipient of the Grodsky Award, is committed to understanding the importance of a specific class of factors for the development and function of the insulin-producing cells in the pancreas. She is also a recipient of the JDRF Career Development Award (2001-2006).


Contact: Jillian Lubarsky
Juvenile Diabetes Research Foundation International

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
Breaking Medicine Technology: